Dimetholizine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O6U9W3DMYT. European Medicines Agency schedules Dimetholizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07174MIG. Dimetholizine generally arises in the molecular formula C15H24N2O2. The term DIMETHOLIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3 1962, list 4.) DIMETHOLIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dimetholizine under HS 29335995 and SITC 51576. As of Q4 2014, DIMETHOLIZINE remains the US FDA Preferred Term for this commodity. Dimetholizine bears US NLM identifiers UMLS ID C1880334 and NCI Concept Code C65405. SMILES: O(CCCN1CCN(CC1)C1C(OC)CCCC1)C.